期刊文献+

多药耐药基因与P53在胃癌组织中表达关系及意义 被引量:1

Relationship and Significance Between MDR-1 and P53 Protein in Carcinoma of Stomach
下载PDF
导出
摘要 目的 :检测多药耐药基因 (MDR - 1 )及P5 3在胃癌组织中的表达关系及其临床意义。方法 :应用免疫组化法研究 5 0例胃癌MDR - 1、P5 3蛋白表达。结果 :5 0例胃癌中MDR - 1、P5 3表达随分化程度降低 ,阳性表达率增高 ,分别为 5 7.42 %和 36.5 % ,二者呈正相关。结论 :应用MDR - 1、P5 Purpose:To investigate the relationship between multidrug-resistance gene and P53 protein in carcinoma of stomach.Methods:Microwave immunohistochemical staining was used to detect MDR-1 and P53 in 50 cases of carcinoma of stomach.Results:The positive rate of MDR-1 and P53 was 57.42% and 36.5% respectively in 50 case carcinoma.The expression of P53 was positively correlated with MDR-1 in vavious differentiated carcinoma of stomach.Conclsion MDR-1 and P53 can be an important in prediction of the prognosis carcinoma patients
出处 《长治医学院学报》 2003年第2期90-91,共2页 Journal of Changzhi Medical College
关键词 胃癌 MDR-1 P53 Gastric cancer P53 MDR-1
  • 相关文献

参考文献5

  • 1刘忠民,寿楠海.大肠癌组织mdr1基因表达的临床意义[J].中国肛肠病杂志,2000,20(4):15-16. 被引量:2
  • 2陆磊,童铭武,杨瑞飞.大肠癌MDR_(-1)与p53表达关系及其意义[J].中国癌症杂志,1999,9(1):47-48. 被引量:2
  • 3Schuurhuis G J, Broxteman HJ. BeaK JPA. et al. Functional MDR Associated with Combined overperssion of MDR - 1 and MRP together with drug se-sitivity may predict clinical, response in AML. Clin Cancer Res, 1995,81:81.
  • 4Dervite I ,Morel P,Fenaux P.P53 mutations are associated with resistance to chmotherapy and short surrival in bamatologic malignaneies.Blood, 1994,84:3148.
  • 5Nooter K, Herweijer H. Multidrug resistance (mdr) genes in human cancer. BrJ Cancer, 1991,63:663.

二级参考文献1

  • 1高振强 高志萍.多药耐药基因研究进展[J].中华病理学杂志,1992,255:459-459.

共引文献2

同被引文献7

引证文献1

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部